This announcement is a separate document:
申万宏源证券承销保荐有限责任公司关于杭州奥泰生物技术股份有限公司调整2024年度日常关联交易预计额度的核查意见
Verification opinions of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on Hangzhou Aotai Biotechnology Co., Ltd.\'s adjustment of the estimated quota for daily related transactions in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.